1 insiders reported 12 Form 4 transactions for Greenwich LifeSciences, Inc. (GLSI) over the past 18 months (most recent 2026-01-15). Recent activity: Patel Snehal (CEO and CFO) Buy 1,800 shares, Patel Snehal (CEO and CFO) Buy 2,900 shares, Patel Snehal (CEO and CFO) Buy 4,300 shares, Patel Snehal (CEO and CFO) Buy 2,900 shares, Patel Snehal (CEO and CFO) Buy 4,100 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-15 | Patel Snehal | CEO and CFO | Buy | 1,800 | $53,694 |
| 2026-01-14 | Patel Snehal | CEO and CFO | Buy | 2,900 | $79,866 |
| 2026-01-05 | Patel Snehal | CEO and CFO | Buy | 4,300 | $91,848 |
| 2026-01-02 | Patel Snehal | CEO and CFO | Buy | 2,900 | $63,017 |
| 2025-12-19 | Patel Snehal | CEO and CFO | Buy | 4,100 | $51,742 |
| 2025-11-28 | Patel Snehal | CEO and CFO | Buy | 4,600 | $38,502 |
| 2025-11-12 | Patel Snehal | CEO and CFO | Buy | 10,600 | $89,358 |
| 2025-11-04 | Patel Snehal | CEO and CFO | Buy | 2,300 | $21,298 |
| 2025-04-29 | Patel Snehal | CEO and CFO | Buy | 3,600 | $35,568 |
| 2025-04-22 | Patel Snehal | CEO and CFO | Buy | 5,400 | $48,492 |
| 2025-04-08 | Patel Snehal | CEO and CFO | Buy | 3,600 | $32,760 |
| 2025-04-07 | Patel Snehal | CEO and CFO | Buy | 5,500 | $48,015 |
Source: SEC Form 4 filings · as of 2026-01-15